BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on oncology. The Company’s business model is to in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development and/or commercialization.

The Company’s lead program, Motixafortide (BL-8040), is a cancer therapy platform currently being evaluated in a Phase 2a study for the treatment of pancreatic more

Upcoming Events View all

Sep 24, 2020 at 3:00 AM EDT

Annual General Meeting of Shareholders 2020

Sep 24, 2020 at 3:00 AM EDT

2020 אסיפה כללית שנתית

I.R. Contacts

If you would like further information or have questions or comments, please contact:

Tim McCarthy
LifeSci Advisors, LLC

Media inquiries:

Moran Meir
LifeSci Advisors, LLC